Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:57 PM UTC
| NCT Number | NCT06690775 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 26 sites in the US |
| Sponsor | TORL Biotherapeutics, LLC |
| Last Updated on CT.gov | December 23, 2025 (Dec 23, 2025) |
As of July 18, 2026: Clinical trial NCT06690775 is currently recruiting participants. This phase2 study for ovarian cancer is actively seeking new participants at 26 locations across the United States. The study is sponsored by TORL Biotherapeutics, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06690775 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06690775 was last updated Dec 23, 2025 (December 23, 2025). HelloStudys verifies this status automatically.